the aid library

LIST OPTIONS

Filter

2351

Sort by:

Direction:

Download (575)

View PDF (1289)

Influenza Pandemic Preparedness and Response Plan

Ministry of Health and Family Welfare Nirman Bhawan New Delhi (2006) C1

Download (202)

View PDF (890)

Tuberculosis - Prevention in travellers

A. A. Neilson, C. A. Mayer RACGP (2010) C2

Reprinted from Australian Family Physician Vol. 39, No. 10, october 2010

Download (1752)

View PDF (2095)

Study on the Gendered Impacts of Ebola in Liberia (February 2015)

Leena Kotilainen Finn Church Aid (2015)

This study examines the gendered impacts of the Ebola virus disease (EVD) in Liberia in the largest outbreak of EVD ever recorded. The findings are based on an extensive two-week desk study and one-week participatory field study conducted in January 2015 in the cities of Monrovia and Buchanan in Lib... more

Download (1037)

View PDF (1171)

Liberia National Drug Policy 2001

Ministry of Health and Social Welfare, Liberia (2010) C1

Download (296)

View PDF (1192)

Empfehlungen zur Diagnostik und Therapie nichttuberkulöser Mykobakteriosen

N. Schönfeld, W. Haas, E. Richter et al. (2013) C2

des Deutschen Zentralkomitees zur Bekämpfung der Tuberkulose (DZK) und der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin (DGP) Recommendations for Diagnosis and Treatment of Nontuberculous Mycobacterioses of the German Central Committee against Tuberculosis and the German Respirator... more

Download (662)

View PDF (1754)

Australian Guidelines for the Prevention of Infection in Health Care 2010

Australian Commission on Safety and Quality in Health Care (ACSQHC) (2010) C1

An Update will be published in late 2018

Download (1190)

View PDF (1328)

Medicinal products under development for the treatment of Ebola

European Medicines Agency EMA (2014)

Interim Assessement Report The EMA review was started by the Agency’s Committee for Medicinal Products for Human Use (CHMP) to support decision-making by health authorities. This first interim report includes information on seven experimental medicines intended for the treatment of people infecte... more

Download (462)

View PDF (760)

Screening donated blood for transfusion-transmissible infections: recommendations

World Health Organization (WHO) (2009) C_WHO

The provision of safe and efficacious blood and blood components for transfusion or manufacturing use involves a number of processes, from the selection of blood donors and the collection, processing and testing of blood donations to the testing of patient samples, the issue of compatible blood and ... more

Download (599)

View PDF (701)

Guidelines for Diagnosis and Treatment of Malaria in India 2014

NATIONAL INSTITUTE OF MALARIA RESEARCH NEW DELHI (2014) C1

Download (2411)

View PDF (1690)

Malaria Diagnosis and Treatment Guidelines for Health Workers in Ethiopia

Ministry of Health, Ethiopia (2004) C1

Download (7286)

View PDF (4761)

National Guidelines for the Diagnosis, Treatment and Prevention of Malaria in Kenya
recommended

Ministry of Public Health and Sanitation, Ministry of Medical Services (2010) C1

Download (140)

View PDF (176)

Traditional and alternative medicine treatments in child and adolescent mental health

N. L. Soh; G. Walter IACAPAP (2012) C2

Miscellaneous Chapter J.2

Download (120)

View PDF (152)

Commisson Notice: Guidelines for the prudent use of antimicrobials in veterinary medicine

Official Journal of the European Union (2015) C2

The extensive use of antimicrobials in human and veterinary medicine in recent years has accelerated the emergence and spread of resistant microorganisms. This situation has been worsened by the lack of investment in developing new effective antibiotics. The severity of the consequences is clear to ... more

Download (98)

View PDF (996)

Antimicrobial Resistance: Challenges and Perspectives

Doyle, M.P.; G. H. Loneragan, H. M. Scott et al. (2006) C2

Comprehensive Reviews in Food Science and Food Safety, Vol.12 (2013) pp.234-248 In 2006, the Institute of Food Technologists (IFT) published an Expert Report entitled “Antimicrobial Resistance: Implications for the Food System” (IFT 2006). That report summarized current scientiﬁc knowledge pe... more

Download (169)

View PDF (230)

Buruli ulcer laboratory network and new external quality assessment programme for PCR-based diagnosis in the WHO African Region. Terms of reference

World Health Organization WHO (2020) C_WHO

A total of 18 laboratories from 13 countries participated in the four rounds of EQA: 10 laboratories from eight African endemic countries, four of which participated in all four rounds and three in three rounds. The overall results showed that the median performance of these laboratories improved ov... more

Download (1395)

View PDF (4121)

Measles outbreak guide
recommended

World Health Organization WHO (2022) C_WHO

This guide also draws on the standard operating procedures (SOPs) to apply for measles outbreak response support from the Measles & Rubella Initiative Outbreak Response Fund (17) and includes a section on measles outbreak recovery so that contributing factors and potential root causes are identifi... more

Download (179)

View PDF (180)

Operational guide: use of referral laboratories for the analysis of foodborne hazards in the Pacific

World Health Organisation (WHO) (2023) C_WHO

The Operational guide: use of referral laboratories for the analysis of foodborne hazards in the Pacific aims to strengthen the food analysis capacity of Pacific Island countries and areas by identifying national and reference laboratories capable of testing for priority foodborne hazards. The Pacif... more

Download (210)

View PDF (180)

A checklist for respiratory pathogen pandemic preparedness planning

World Health Organization WHO (2023) C_WHO

This checklist is an operational tool to help national authorities develop or revise national respiratory pathogen (inclusive of influenza and coronaviruses) pandemic preparedness plans.

Download (42)

View PDF (29)

Operational guidance on the use of yellow fever assays in the context of surveillance

World Health Organization WHO (2023) C_WHO

This publication aims to provide updated guidance on the specific use of yellow fever laboratory assays in the context of surveillance to be used across the Global Yellow Fever Laboratory Network for disease surveillance. In the recent years, new commercial assays became available and are now recomm... more

Download (7)

View PDF (6)

Mpox Testing Strategy - November 2024

Africa Center for Disease Control and Prevention (2024) CC

Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...d in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries. In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response. As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa. more

National Guidelines for the Diagnosis, Treatment and Prevention of Malaria in Kenya recommended

Measles outbreak guide recommended

National Guidelines for the Diagnosis, Treatment and Prevention of Malaria in Kenya
recommended

Measles outbreak guide
recommended